Lamotrigine Tablet
Product Images NDC 60687-704

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 60687-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

150 mg Lamotrigine Tablet Blister (150 mg Blister)

150 mg Lamotrigine Tablet Blister (150 mg Blister)
Lamotrigine is a medication with a dosage of 150mg and the brand name SuLE. The rest of the text is not interpretable.*
FDA Label Image

150 mg Lamotrigine Tablets Carton (150 mg Carton)

150 mg Lamotrigine Tablets Carton (150 mg Carton)
This is a description of Lamotrigine tablets, USP. The NDC number is 60687-693-01 and the medication comes in a package of 100 tablets (10 x 10). Each tablet contains 150mg of Lamotrigine, USP. The package insert should be referred to for full prescribing information. The medication should be stored in a dry place at room temperature. The drug is dispensed with accompanying medication by a pharmacist and should be verified before use. The manufacturer of the drug is American Health Packaging and the distributor is located in Columbus, Ohio.*
FDA Label Image

200 mg Lamotrigine Tablets Carton (200 mg Carton)

200 mg Lamotrigine Tablets Carton (200 mg Carton)
This is a medication description for Lamotrigine tablets, USP, which come in a package of 100 tablets (10x10). Each tablet contains 200mg of the active ingredient, Lamotrigine USP. The usual dosage is mentioned in the insert. It is important to verify the product dispensed as each tablet is to be taken with the accompanying Medication Guide. The package must be stored in a dry place at a recommended room temperature. This medication must be kept out of reach of children, and not used if the blister is torn or broken. The drug product contains NDC # 68382-010 from Zycus Pharmaceuticals (USA) Inc., and is distributed by American Health Packaging in Columbus, Ohio.*
FDA Label Image

Ahp69301

Ahp69301
FDA Label Image

Ahp70401

Ahp70401
FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Figure1)

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Figure1)
FDA Label Image

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Figure2)

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Figure2)
The given text is related to the failure probability (%) of Lamotrigine, a medication used for epilepsy and bipolar disorder. The failure probability is 100%, and there appears to be some "censored" information that is not visible. Additionally, the failure probability is at 80%.*
FDA Label Image

Lamotrigine Tablets For Oral Suspension (Os Tablets)

Lamotrigine Tablets For Oral Suspension (Os Tablets)
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
FDA Label Image

Lamotrigine Tablets (Tablets)

Lamotrigine Tablets (Tablets)
FDA Label Image

200 mg Lamotrigine Tablet Blister (Image 01)

200 mg Lamotrigine Tablet Blister (Image 01)
This is a text containing information related to Lamotrigine medication. The text seems to be a mix of different dosages and lot numbers of Lamotrigine Tablet, USP. There is not enough clear information to determine dosage, usage, or administration instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.